D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy

Arnt, 1985, Behavioral stimulation is induced by separate dopamine D1 and D2 receptor sites in reserpine-pretreated but not in normal rats, Eur J Pharmacol, 113, 79, 10.1016/0014-2999(85)90345-0 Billard, 1984, Characterization of the binding of 3H-SCH 23390, a selective D1 receptor antagonist ligand, in rat striatum, Life Sci, 35, 1885, 10.1016/0024-3205(84)90540-X Boyce, 1985, SCH 23390 may alter dopamine-mediated motor behavior via striatal D1 receptors, Biochem Pharmacol, 34, 1665, 10.1016/0006-2952(85)90632-X Christensen, 1984, Pharmacological effects of a specific dopamine D1 antagonist SCH 23390 in comparison with neuroleptics, Life Sci, 34, 1529, 10.1016/0024-3205(84)90607-6 Costall, 1975, Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine, Psychopharmacologia, 43, 69, 10.1007/BF00437617 Creese, 1985, Selective D1 dopamine receptor increase following chronic treatment with SCH 23390, Eur J Pharmacol, 109, 127, 10.1016/0014-2999(85)90549-7 Finney, 1952 Goetz, 1983, Animal models of tardive dyskinesia: Their use in the search for new treatment methods, Mod Probl Pharmacopsychiatry, 21, 5, 10.1159/000408479 Haley, 1957, Pharmacological effect produced by intracerebral injection of drugs in the conscious mouse, Br J Pharmacol, 12, 12 Hemmings, 1984, DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated neuronal phosphoprotein, J Biol Chem, 259, 14486, 10.1016/S0021-9258(17)42625-1 Iorio, 1983, SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems, J Pharmacol Exp Ther, 226, 462 Kebabian, 1979, Multiple receptors for dopamine, Nature, 277, 93, 10.1038/277093a0 Lowry, 1951, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 Meller, 1985, Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroisoquinoline in vivo: Selective protection by neuroleptics, J Pharmacol Exp Ther, 233, 656 Meller, 1985, Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist, Life Sci, 36, 1857, 10.1016/0024-3205(85)90159-6 Molloy, 1984, Dopaminergic behavior stereospecifically promoted by the D1 agonist R-SKF 38393 and selectively blocked by the D1 antagonist SCH 23390, Psychopharmacology (Berlin), 82, 409, 10.1007/BF00427697 Morelli, 1985, Catalepsy induced by SCH 23390 in rats, Eur J Pharmacol, 117, 179, 10.1016/0014-2999(85)90602-8 Onali, 1984, Selective blockade of dopamine D1 receptors by SCH 23390 discloses striatal dopamine D2 receptors mediating the inhibition of adenylate cyclase in rats, Eur J Pharmacol, 99, 127, 10.1016/0014-2999(84)90445-X Porceddu, 1985, Chronic blockade of D1 dopamine receptors increases 3H-SCH 23390 binding sites in the rat striatum, Soc Neurosci Abstr, 11, 456 Pugh, 1985, Effects of the putative D1 antagonist SCH 23390 on stereotyped behavior induced by the D-2 agonist RU24213, Psychopharmacology (Berlin), 37, 308, 10.1007/BF00432713 Smith, 1976, Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine and thioridazine, Life Sci, 19, 725, 10.1016/0024-3205(76)90170-3 Stoof, 1984, Two dopamine receptors: Biochemistry, physiology and pharmacology, Life Sci, 35, 2281, 10.1016/0024-3205(84)90519-8 Tarsy, 1973, Pharmacologically induced behavioral supersensitivity to apomorphine, Nature [New Biol], 245, 262, 10.1038/newbio245262a0